There is increasing evidence for a centrally mediated inhibitory effect of the amino-acid neurotransmitter y-aminobutyric acid (GABA) on the hypothalamo-pituitary-adrenal axis. In the present study, the direct effect of GABA in modulating the release of the 41-residue corticotrophin-releasing factor (CRF-41), the major CRF identified so far, was investigated in acute hypothalamic explants by utilizing previously validated incubation and assay techniques. While GABA (lo-' to M) had no effect on basal CRF-41 release (P>0.05), it significantly suppressed K' (28 mM)-stimulated release in a dose-dependent manner (PiO.01). A similar inhibitory effect was observed with the GABA, agonist muscimol to M). Noradrenaline M)-induced CRF-41 release was also significantly inhibited by GABA 10-M. The inhibitory effect of GABA on K+-stimulated CRF-41 secretion was completely.reversed by the GABA antagonists bicuculline and picrotoxin M) in a dose-dependent fashion. Both bicuculline and picrotoxin stimulated basal and K + (28 mM)-stimulated CRF-41 release, indicating the presence of tonic inhibition by endogenous GABA in the basal state. Finally, GABA M was able to significantly inhibit the stimulated release of CRF-41 from the isolated median eminence.In summary, the present data provide strong evidence that GABA-induced inhibition of the hypothalamo-pituitary-adrenal axis is mediated, at least in part, through an inhibitory action on CRF-41 secretion. It is likely that these GABA receptors are located directly on CRF-41 neurons, probably on nerve terminals in the median eminence.
toIn recent years progress in our knowledge on the neurotransmitter control of the pituitary-adrenal axis has suggested an important role for y-aminobutyric acid (GABA) on adrenocorticotrophin (ACTH) secretion. In particular, studies both in vivo (1-3) and in vitro (4, 5), the latter measuring the release of bioactive corticotrophin-releasing factor(s) (CRF), have demonstrated an inhibitory role for GABA in the regulation of ACTH and glucocorticoid secretion, and have provided good evidence for a central site of action (4, 5). Furthermore, recent immunohistochemical data have clearly shown a close relationship between hypothalamic GABAergic neurons and neurons containing the 41-residue C R F (CRF-41) (6, 7). However, there are currently few data on the role of GABA in regulating the rcleasc of CRF-41, although a recent study has demonstrated inhibition of acetylcholine-stimulated release by GABA at a single dose (8, 9). In the present study, therefore, we have investigated the direct effect of GABA in modulating the release of CRF-41 from acute hypothalamic explants in vitro, using previously validated incubation and assay techniques (10).
ResultsAs shown in Fig. 1, GABA in the concentration range lo-' to 10-M significantly suppressed KC1 (28 mM)-stimulated release in a dose-dependent manner (P < 0.01); this was significantly different to the control incubation at both M and M, but not at M. GABA lo-' M was without effect. The GABA, receptor ag...